SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-009471
Filing Date
2022-03-10
Accepted
2022-03-10 07:05:31
Documents
13
Period of Report
2022-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srra-8k_20220310.htm   iXBRL 8-K 42801
2 EX-99.1 srra-ex991_7.htm EX-99.1 322670
  Complete submission text file 0001564590-22-009471.txt   512171

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA srra-20220310.xsd EX-101.SCH 5693
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20220310_lab.xml EX-101.LAB 19322
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20220310_pre.xml EX-101.PRE 11492
7 EXTRACTED XBRL INSTANCE DOCUMENT srra-8k_20220310_htm.xml XML 3538
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 22727368
SIC: 2834 Pharmaceutical Preparations